Keep up to date with MTPConnect news and events, updated regularly. If you have news or events the sector would be interested to hear about, please let us know at firstname.lastname@example.org.
08 April 2022
MTPConnect co-exhibitor on the Australian Pavilion at world’s largest biotechnology convention BIO 2022
As part of its commitment to opening international markets and boosting access to international supply chains, MTPConnect has joined the AusBiotech-led Australian Pavilion as co-exhibitor at the BIO International Convention 2022 in San Diego, California.
06 April 2022
MTPConnect to fund DMTC project for Artificial Intelligence-assisted deep dive into health biosecurity capability
MTPConnect has announced it is funding a new project with DMTC Limited to provide a picture of the capability and capacity of Australia’s health biosecurity ecosystem. This will include end-to-end supply chains and workforce. Leveraging funding for MTPConnect from the Australian Government, the project will use Artificial Intelligence (AI) and machine learning to create a comprehensive digital database of sovereign capability and capacity in the health biosecurity sector.
06 April 2022
MTPConnect and Pathology Technology Australia to Develop Action Plan to Build Sovereign Manufacturing Capability in Diagnostic Tests
MTPConnect has secured funding from the Australian Government to develop a national Action Plan for building end-to-end sovereign manufacturing capability for diagnostic tests. The Action Plan will be developed in close partnership with Pathology Technology Australia (PTA) - the peak body representing manufacturers and suppliers of tests and technology used in pathology laboratories, hospitals, general practice and for self-testing.
05 April 2022
Pioneering Australian technology is keeping hospitals COVID-safe
Read our latest case study on the Medihood - a groundbreaking patient isolation hood developed by a multidisciplinary team of world-leading experts led by the University of Melbourne that protects healthcare workers and nearby patients from COVID-19 and other infectious respiratory diseases. Supported by our BTB program with MRFF funding.
04 April 2022
Cancer Therapeutics CRC/Canthera Discovery win Research Commercialisation Award
Canthera Discovery's predecessor, Cancer Therapeutics CRC, wins the Cooperative Research Australia (CRA) Excellence in Innovation Award for Research Commercialisation at an award ceremony at Parliament House in Canberra last week.
04 April 2022
Introducing Stephanie Morris - Director of Innovation and Translation - Adelaide Intermediary Program
We are excited to welcome Stephanie Morris to MTPConnect as the Director of Innovation and Translation for our Adelaide Intermediary Program, based in Adelaide.
31 March 2022
Call for Medtech and Biotech companies to participate in the Franklin Women Mentoring Program
Now in its 6th year, this cross-organisational Mentoring program aims to support mid-career women working in health and medical research ecosystem on their journey to leadership roles. In 2022, the unique program will be delivered in both Sydney and Canberra starting in May. Applications are open until 15 April 2022.
24 March 2022
MTPConnect meets up with BioNTech team in Sydney
Senior representatives of BioNTech, the company behind Pfizer’s COVID-19 vaccine, have been in Australia this week.
23 March 2022
Introducing Natalie Vella - Social Media Specialist
We are delighted to welcome Natalie Vella to our communications team in the role of Social Media Specialist, based in Melbourne.
18 March 2022
WearOptimo backed by Aspen Medical in multi-million-dollar strategic deal
A multi-million-dollar investment agreement by Aspen Medical in Queensland-based health-tech company WearOptimo, has cemented a strategic partnership between the two companies to revolutionise precision medicine globally.
11 March 2022
In Case You Missed It: Here's What The MTPConnect Team Has Been up to in February
Check out what MTPConnect got up to in February!
10 March 2022
Please welcome Deborah Sippitts - Senior Manager Communications
Today we are delighted to announce that Deborah Sippitts is joining MTPConnect as Senior Manager Communications working with Caroline Duell and Libby Pearce, based in Melbourne.
01 March 2022
Cincera: developing a first-in-class drug to treat NASH
In our latest case study, we explain how biotech company Cincera, bolstered by MTPConnect's BTB program, is developing a drug to treat severe and life-threatening liver diseases.
28 February 2022
Life Sciences WA Awarded X-TEND Grant
We are pleased to announce that our partnership with Life Sciences WA (LSWA) has been awarded an X-TEND WA program grant, supported by the Department of Jobs, Tourism, Science and Innovation and part of the New Industries Fund.
28 February 2022
TTRA Partners with Australia Centre for Health Services Innovation
We are pleased to announce a new TTRA partnership with the Australian Centre for Health Services Innovation (AusHSI), to provide support and mentoring for standalone behavioural intervention applicants and awardees.